Sign in
4

Changes in Ownership

ARS Pharmaceuticals, Inc. Filed Acc 0001193125-26-285521

Options or other derivatives

  • Director acquired 30,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table II: Derivative

Insider Date Transaction Shares Price Value Owned after D/I
Dadoo Rajeev Director 2026-06-24 Grant or award · Stock Option (right to buy) +30,000 30,000 D: show line 1 in the form
Loading xslF345X06/ownership.xml…